07/10/2011 LA 1

PHARMACY PRACTICE MODULE PHARMACY PRACTICE-III PHR-3106 Third year 8 credits Lecturers: A. Serracino Inglott, L.M. Azzopardi Lecture Schedule

Lecture

No.

Lecture Title

Description

Lecturer

1

24/10/11

Research methodology-III

Observational methods Surveys Questionnaire construction Data preparation and analysis

LA

2

24/10/11

Schizophrenia

Schizophrenia, which is a chronic, debilitating illness where the goal of treatment is to control psychotic symptoms, is discussed. A comparative approach to antipyschotic medications is adopted.

LA

3

31/10/11

Pharmacists’ care plans and Pharmacist Prescribing

Pharmacists are in a position to fill the pharmaceutical care gap that occurs in the practical setting whereby there is lack of optimal amount of therapeutic planning. A general introduction to the planning phase and the development of disease specific drug treatment protocols is presented so as to serve as a basis for disease-oriented discussions in these credits. An introduction to the concept of pharmacist prescribing is presented.

ASI

4

31/10/11

Cardiovascular disorders

The pharmacists interventions during the diagnostic and treatment phases are aimed to help patients achieve the desired outcomes of therapy. Clinical assessment and parameters that should be monitored in cardiovascular disease are discussed.

ASI

5 7/11/11

Mood disorders

Depression is an affective disorder where patient presents with varying degrees of low mood. Drug treatment is the mainstay of treatment in moderate to severe depression but for treatment to be successful it should be supported by non-pharmacologic strategies. Management of acute and major depression is discussed.

LA

6

7/11/11

Hypertension

The management of hypertension, which is considered a major risk factor for cardiovascular and cerebrovascular disease, is discussed. Review of causes of lack of responsiveness to antihypertensive therapy and of considerations for individualizing drug therapy due to co-existing disease states.

ASI

07/10/2011 LA 2

7

14/11/11

Hypertension II

The management of hypertension, which is considered a major risk factor for cardiovascular and cerebrovascular disease, is discussed. Review of causes of lack of responsiveness to antihypertensive therapy and of considerations for individualizing drug therapy due to co-existing disease states.

ASI

8

14/11/11

Mood disorders II

Depression is an affective disorder where patient presents with varying degrees of low mood. Drug treatment is the mainstay of treatment in moderate to severe depression but for treatment to be successful it should be supported by non-pharmacologic strategies. Management of acute and major depression is discussed.

LA

9

21/11/11

Ischaemic heart disease

A condition where there is impairment in the supply of oxygenated blood to cardiac tissue. Treatment of risk factors is discussed and patient education necessary is emphasised.

ASI

10

21/11/11

Anxiety disorders

Diagnostic criteria to differentiate generalized anxiety disorder from the normal response to stress are reviewed. The use of antidepressants and benzodiazepines in the treatment of anxiety disorder is discussed.

LA

11

28/11/11

Congestive heart failure

The goal of therapy in cardiac failure is to control symptoms of heart failure. Medications used to treat heart failure with special reference to common management mistakes are discussed.

ASI

12

28/11/11

Sleep disorders

Difficulties in falling asleep or staying asleep or lack of refreshment from sleep are common complaints. The rational use of hypnotic drugs and the counselling that should be undertaken on proper sleep hygiene are discussed.

LA

13

12/12/11

Hyperlipidaemia

When hyperlipidaemia is uncontrolled by diet and lifestyle modifications alone, drug therapy is considered. Review of drug therapy, risk of side effects and medication expenses and dietary compliance.

ASI

14

12/12/11

Eating disorders

Eating disorders are discussed with special reference to anorexia nervosa and bulimia.

LA

15

19/12/11

Thrombosis

Management of thrombosis with particular reference to patient education.

ASI

16

19/12/11

Antihistamine drugs and allergic rhinitis

Comparative approach to antihistamine drugs used for allergic rhinitis and the common cold.

LA

17 9/01/12 Skin Disorders Management of skin allergies, acne ASI

07/10/2011 LA 3

and psoriasis is reviewed.

18

9/01/12

Genito-urinary disorders

Use of drugs for urinary retention, urinary incontinence and urological pain is reviewed.

LA

19

16/01/12

Dispensing of adrenergic and cholinergic drugs

Review of adrenergic drugs, cholinergic and cholinergic blocking drugs; their indications, side effects to be expected and patient counselling.

ASI

20

16/01/12

Menopause and Hormone replacement therapy (HRT)

Menopause is associated with problems resulting from the ensuing loss of oestrogen in the body. HRT is discussed considering advantages offered, pharmaceutical dosage forms available and patient education.

LA

21 13/02/12

Dementia and Alzheimer’s disease

Treatment options in particular innovative disease-specific therapy are discussed. Measurement of patients’ quality of life and of the decline in cognitive symptoms will be presented as pharmacotherapy outcome measurements.

ASI

22 13/02/12

Menstrual cycle disorders and contraception

Occurrence of menstrual cycle disorders and treatment options is discussed. Oral contraception with emphasis on patient counselling and on the various preparations available is discussed.

LA

23 20/02/12

Risks and use of medicines

Medication errors are a cause of concern and require establishment of controlled drug distribution systems and comprehensive pharmacy services. Methods and issues considered in addressing this issue are discussed.

ASI

24 20/02/12

Quality standards in pharmacy practice

The concept of evaluation of professional services provided by the pharmacist is presented. Methods adopted to evaluate quality of professional services provided are reviewed. Audit exercises and validation tools are discussed.

LA

25 27/02/12 Hepatitis infection

The management of viral infectious diseases will be discussed taking as an example Hepatitis infection. Various treatment modalities are presented.

ASI

26 27/02/12 HIV infection

The treatment regimens used in the management of HIV infected patients are discussed. Pharmacist interventions in this speciality are presented.

LA

5-9/03/12 Pharmacy Symposium ASI/LA

12/03/12 Discussion ASI/LA

26 March –18 May

Practical attachments